Matt Miksic is a Managing Director and Senior Research Analyst at Piper Jaffray, where he covers medical technology and hospital supply stocks with an emphasis on orthopedics, spine and ophthalmology. Mr. Miksic joined Piper Jaffray after eight years in equity research at Morgan Stanley, where he was a member of the medical technology and hospital supply coverage team since 2002, with lead coverage of orthopedics, spine and hospital supplies. Prior to Morgan Stanley, Mr. Miksic was a Senior Manager with Arthur Andersen in its business consulting division, and he spent five years with a software startup. Mr. Miksic holds a bachelor’s degree in computer science from Rutgers College and a Master of Business Administration degree from the Leonard N. Stern School of Business at New York University.
